1. Home
  2. DGLY vs SBFM Comparison

DGLY vs SBFM Comparison

Compare DGLY & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGLY
  • SBFM
  • Stock Information
  • Founded
  • DGLY N/A
  • SBFM 2006
  • Country
  • DGLY United States
  • SBFM Canada
  • Employees
  • DGLY N/A
  • SBFM N/A
  • Industry
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGLY Technology
  • SBFM Health Care
  • Exchange
  • DGLY Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • DGLY 8.4M
  • SBFM 7.4M
  • IPO Year
  • DGLY N/A
  • SBFM N/A
  • Fundamental
  • Price
  • DGLY $2.15
  • SBFM $0.33
  • Analyst Decision
  • DGLY
  • SBFM Strong Buy
  • Analyst Count
  • DGLY 0
  • SBFM 1
  • Target Price
  • DGLY N/A
  • SBFM $260.00
  • AVG Volume (30 Days)
  • DGLY 16.4K
  • SBFM 3.3M
  • Earning Date
  • DGLY 08-12-2024
  • SBFM 08-08-2024
  • Dividend Yield
  • DGLY N/A
  • SBFM N/A
  • EPS Growth
  • DGLY N/A
  • SBFM N/A
  • EPS
  • DGLY N/A
  • SBFM N/A
  • Revenue
  • DGLY $26,080,507.00
  • SBFM $26,739,780.00
  • Revenue This Year
  • DGLY $22.14
  • SBFM $87.97
  • Revenue Next Year
  • DGLY N/A
  • SBFM $125.23
  • P/E Ratio
  • DGLY N/A
  • SBFM N/A
  • Revenue Growth
  • DGLY N/A
  • SBFM 193.30
  • 52 Week Low
  • DGLY $1.73
  • SBFM $0.28
  • 52 Week High
  • DGLY $4.40
  • SBFM $64.50
  • Technical
  • Relative Strength Index (RSI)
  • DGLY 39.07
  • SBFM 35.00
  • Support Level
  • DGLY $2.04
  • SBFM $0.29
  • Resistance Level
  • DGLY $2.45
  • SBFM $0.38
  • Average True Range (ATR)
  • DGLY 0.17
  • SBFM 0.05
  • MACD
  • DGLY -0.02
  • SBFM 0.05
  • Stochastic Oscillator
  • DGLY 25.41
  • SBFM 24.31

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Share on Social Networks: